Charité Universitätsmedizin Berlin
Charité – Universitätsmedizin Berlin represents a single medical faculty, which serves both Humboldt Universität zu Berlin and Freie Universität Berlin. Charité has almost 100 different departments and institutes, extending over four campuses. It is home to 3,700 researchers and physicians who are actively engaged in delivering clinical care, research and teaching of the highest international standard and across the full range of medical disciplines. Charité is internationally renowned for its excellence in teaching and research – a reputation that is in no small part due to numerous neuroscience initiatives, including major contributions from the Department of Neuropathology. The department, whose clinical and research operations are closely interlinked, has approximately 50 employees. By combining basic and clinical research efforts, the department is well positioned to further our understanding of neurological diseases, and provide a basis for continued developments in the diagnosis and treatment of neurological disorders.
For more information, please visit our website.
Project Leader: Prof. Dr. med. Frank Heppner (Chairman | Department of Neuropathology)
Fraunhofer-Institut St. Augustin
In compliance with the general mission of a Fraunhofer Institute, the Department of Bioinformatics is working closely with industrial partners – including small and medium size enterprises - to enhance their competitiveness through mediating knowledge and technology transfer from academic research to industrial application. Collaborative research and development projects of the Department of Bioinformatics deliver solutions to the pharmaceutical industry, the biotech industry and to the life science software industry. Positioned at the boundary between pure commercial and pure academic research we maintain strong links to both communities established also in several IMI projects like Aetionomy, Open PHACTS and EPATH.
For more information, please visit our website.
Project Leader: Prof. Dr. Martin Hofmann-Apitius (Head of Department)
German Center of Neurodegenerative Diseases
The German Center for Neurodegenerative Diseases (DZNE) is a new, interdisciplinary research center, established in 2009 by Federal Ministry of Education and Research (BMBF) to bundle scientific resources on neurodegenerative diseases and to advance research results towards translational medicine. At nine high-performing sites in Berlin, Bonn, Dresden, Göttingen, Magdeburg, Munich, Rostock/Greifswald, Tübingen and Witten more than 900 employees in more than 80 research groups are investigating various brain diseases. Fields of research include the major neurodegenerative diseases such as Alzheimer's and other dementias, Parkinson's disease, and also rare conditions such as ataxia, amyotrophic lateral sclerosis (ALS) and prion diseases. The core objectives of the DZNE research are to understand the causes of and risk factors for neurodegenerative diseases, and to develop new therapeutic and preventive strategies by translating fundamental discoveries into clinical and public health applications. DZNE investigators work closely together with partners from universities, research institutions, hospitals and the pharmaceutical industry.
For more information, please visit our website.
Project Leader: Christian Haass (Site speaker | group leader DZNE-Munich)
Project Leader: Michael Heneka (Cooperation Unit leader | group leader DZNE-Bonn)
King’s College London
King's College London is one of the top 25 universities in the world (2016/17 QS World University Rankings) and among the oldest in England. King's has more than 26,500 students (of whom nearly 10,400 are graduate students) from some 150 countries worldwide, and nearly 6,900 staff.
King's has an outstanding reputation for world-class teaching and cutting-edge research. In the 2014 UK Research Excellence Framework (REF), eighty-four per cent of research at King’s was deemed ‘world-leading’ or ‘internationally excellent’ (3* and 4*). The university is in the top seven UK universities for research earnings and has an overall annual income of more than £600 million.
King's College London and Guy's and St Thomas', King's College Hospital and South London and Maudsley NHS Foundation Trusts are part of King's Health Partners. King's Health Partners Academic Health Sciences Centre (AHSC) is a pioneering global collaboration between one of the world's leading research-led universities and three of London's most successful NHS Foundation Trusts, including leading teaching hospitals and comprehensive mental health services.
For more information, please visit our website.
Project Leader: Dr. Angela Hodges
Universitätsklinikum Bonn
The University Hospital of Bonn (UKB) covers the full spectrum of medical services and public health care. The UKB hosts the Faculty of Medicine as part of the Rheinische Friedrich-Wilhelms-Universität of Bonn to perform teaching and research in life sciences. Major research topics of the Medical Faculty are neurosciences, immunology and genetic medicine. Research on neurodegenerative diseases is conducted in close collaboration with the German Center for Neurodegenerative Diseases (DZNE) of Bonn.
For more information, please visit our website.
Project Coordinator: Harald Neumann (Professor)
Project Leader: Jochen Walter (Professor)
University College London
UCL is London's leading multidisciplinary university, with approximately 11,000 staff and 38,000 students from 150 different countries. Founded in 1826 in the heart of London, UCL was the first university in England to welcome students of any class, religion, and the first to welcome women on equal terms with men. UCL's founding principles of academic excellence and research aimed at addressing real-world problems continue to inform our ethos to this day.
UCL is one of the world’s leading multi-disciplinary universities. UCL is the top rated university in the UK for research power. The Institute of Neurology is part of the UCL Faculty of Brain Sciences and is home to some of the most influential researchers in neuroscience, dementia, mental health and many more specialist areas of brain sciences.
For more information, please visit our website.
Project Leader: Dr. Jennifer Pocock (Senior Lecturer)
University of Cambridge
The University of Cambridge is a public university, devoted to research and teaching, founded in 1209 in Cambridge, England. Cambridge University includes 31 constituent colleges and over 100 academic departments. Cambridge is consistently ranked as one of the world's best universities, and 95 Nobel laureates have been affiliated with the University. In 2015, the university had a total income of £1.64 billion, of which £398 million was from research grants and contracts.
For more information, please visit our website.
Project Leader: Guy Brown (Professor of Cellular Biochemistry)
University of Gothenburg
The University of Gothenburg (UGOT) is among the largest universities in Northern Europe with approx. 37 000 students and 6 000 employees. With its eight faculties, the University is also one of the most wide-ranging and versatile university in Sweden. The Faculty of Health Science (Sahlgrenska Academy) provides education and conducts research in the fields of pharmacy, medicine, odontology, and healthcare sciences in close collaboration with the Sahlgrenska University Hospital. With 4000 students, 1000 PhD students and 1500 employees it is the largest Faculty of the university. Preclinical and clinical research at the Sahlgrenska Academy is very strong with Neurochemistry being one of its top scientific areas. In this project, the partner will provide expertise in the reliable measurement of sTREM2 in biofluids using mass spectrometry.
For more information, please visit our website.
Project Leader: Henrik Zetterberg, MD, PhD (Professor of Neurochemistry,
Head | Department of Psychiatry and Neurochemistry at the Sahlgrenska Academy
